References
- BayerAWeilerWOeverhausUSkrotzkıFEStewartWCTwo-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapiesJ Ocul Pharmacol Ther200420647047815684807
- HendererJDWilsonRPMosterMRTimolol/dorzolamide combination therapy as initial treatment for intraocular pressure over 30 mmHgJ Glaucoma20051426727015990605
- FechtnerRDRealiniTFixed combination of topical glaucoma medicationsCurr Opin Ophthalmol20041513213515021225
- StewartWCStewartJADayDSharpeEDEfficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice dailyActa Ophthalmol Scand20038124224612780402
- PfeifferNThe German Latanoprost Fixed Combination Study Group. A comparison of the fixed combination of latanoprost and timolol with its individual componentsGraefes Arch Clin Exp Ophthalmol200224089389912486510
- ShinDFeldmanRMSheuWPSEfficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressureOphthalmology200411127628215019375
- HigginbothamEJFeldmanRStilesMLatanoprost and timolol combination therapy versus monotherapyArch Ophthalmol200212091592212096962
- AlmAStjernschantzJEffects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. a comparison with timololOphthalmology1995102174317529098273